Rize Oncology Inc.
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -91.74% | -70.19% | -84.29% | -55.35% | -36.10% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.93% | 143.56% | 153.21% | 169.99% | 14,793.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -60.35% | -52.03% | -72.64% | -40.40% | -18.36% |
|
|
|||||
| Total Current Assets | -60.35% | -52.03% | -72.64% | -40.40% | -18.36% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -60.35% | -52.03% | -72.64% | -40.40% | -18.36% |
|
|
|||||
| Total Accounts Payable | 239.88% | 46.93% | -77.21% | -62.07% | -38.80% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 164.71% | -- | -- | -- |
| Total Other Current Liabilities | -- | 164.71% | -- | -- | -- |
| Total Current Liabilities | 440.18% | 51.74% | -77.21% | -62.07% | -38.80% |
|
|
|||||
| Total Current Liabilities | 440.18% | 51.74% | -77.21% | -62.07% | -38.80% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 440.18% | 51.74% | -77.21% | -62.07% | -38.80% |
|
|
|||||
| Common Stock & APIC | 6.44% | 15.24% | 8.66% | 9.04% | 8.83% |
| Retained Earnings | -23.89% | -25.89% | -25.88% | -21.29% | -15.19% |
| Treasury Stock & Other | 16.89% | -350.52% | -7.70% | 2.92% | -25.08% |
| Total Common Equity | -77.33% | -59.81% | -72.51% | -39.93% | -17.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -77.33% | -59.81% | -72.51% | -39.93% | -17.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -77.33% | -59.81% | -72.51% | -39.93% | -17.43% |
|
|
|||||